Upregulation of PI3K/Akt/mTOR pathway was shown in FLT3 inhibitor-resistant FLT3-ITD+ AML cells despite inhibition of FLT3 activation by FLT3 inhibitors, suggesting that the resistant cells become FLT3 independent [304,305]. The gene discussed is AKT1; the disease is acute myeloid leukemia.